SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-216496
Filing Date
2018-07-12
Accepted
2018-07-12 08:40:57
Documents
4
Period of Report
2018-07-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d471024d8k.htm 8-K 15235
2 EX-99 d471024dex99.htm EX-99 11476
3 GRAPHIC g4710241.jpg GRAPHIC 15626
4 GRAPHIC g471024g0712001238672.jpg GRAPHIC 3897
  Complete submission text file 0001193125-18-216496.txt   55060
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 18949696
SIC: 2834 Pharmaceutical Preparations